BLAIR WILLIAM & CO/IL

Holdings History for Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Symbol: IKT on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$313,554	152,953	0		$2.05	Q4 2025
30 Sep 2025	0%	-0%	$247,784	152,953	-4,000	-2.5%	$1.62	Q3 2025
30 Jun 2025	0%	+0%	$306,058	156,953	+1,000	+0.64%	$1.95	Q2 2025
31 Mar 2025	0%	+0%	$341,537	155,953	+21,000		$2.19	Q1 2025
31 Dec 2024	0%	+0%	$438,597	134,953	+8,833	+7%	$3.25	Q4 2024
30 Sep 2024	0%	+0%	$163,956	126,120	+10,000	+8.6%	$1.30	Q3 2024
30 Jun 2024	0%	+0%	$140,505	116,120	+39,519	+52%	$1.21	Q2 2024
31 Mar 2024	0%	+0%	$165,458	76,601	+16,333	+27%	$2.16	Q1 2024
31 Dec 2023	0%	+0%	$76,540	60,268	+893	+1.5%	$1.27	Q4 2023
30 Sep 2023	0%	+0%	$82,531	59,375	+1,487	+2.6%	$1.39	Q3 2023
30 Jun 2023	0%	+0%	$208,976	57,888	+57,888	NEW	$3.61	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.